No doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA’s new Platform Technology Designation ...

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...

Applied DNA Sciences Inc (NASDAQ:APDN) reported its financial results for the first quarter of fiscal year 2025, showcasing a notable increase in revenue but also highlighting ongoing challenges with ...

Leuven.IRD (Institute for Rare Diseases), LIGAS (Institute for Genetics and Society) and LIVO (Educational Research Institute). These institutes carry out interdisciplinary research with a societal ...

A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene ...

Cars.com Inc. (NYSE: CARS) (d/b/a "Cars Commerce Inc" or the "Company"), an audience-driven technology company empowering the automotive industry, today announced that it expects to report its ...

Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant ...

For years, scientists have known that Neanderthals and modern humans interbred, leaving behind genetic traces that still ...

Prof, MD, DMRD ( Former Dean, Professor & Head- Radiology, LTMMC & LTMGH ) highlights how the goal of TB elimination by 2050, ...

Market OverviewThe Global Breast Cancer Therapeutics Market  remains one of the most prevalent forms of cancer worldwide, ...

The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics, has ...